Lausanne, Switzerland
Skyviews Life Science is a Switzerland-based advisory company, founded in 2018, with a focus on identifying investment opportunities in precision health and longevity. The company operates at the intersection of biotechnology, advanced nutrition, and digital health, targeting private and public enterprises that offer better drugs, advanced technology platforms, preventive strategies, personalized solutions, and more natural foods to enhance the quality of life.
The team at Skyviews comprises experienced professionals from academic, corporate, consumer, and venture capital backgrounds, leveraging global networks and collaborations with partner organizations to deliver exceptional value to clients, patients, healthcare payors, and capital providers. Their approach is rooted in "P4 medicine," which advocates for a shift from reactive disease care to predictive, preventive, personalized, and participatory healthcare, emphasizing big data, improved lifestyles, and tailored treatments based on the understanding that each individual's health journey is unique.
As an investor, Skyviews Life Science presents opportunities at the forefront of the evolving health and wellness landscape, positioned to capitalize on the increasing demand for personalized healthcare solutions and innovative advancements in biotechnology and digital health. With its strong emphasis on creating value and driving positive impact, Skyviews Life Science stands as a promising player in the precision health and longevity sector.
